Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fel-O-Guard
- Development stage
- Unknown
- Lead developer
- Elanco
- Modality
- Vaccines & Immunotherapeutics
- Administration
- Subcutaneous
01
Overview
Fel-O-Guard is a brand of veterinary vaccines for cats, designed to provide protection against various feline diseases. Specific formulations under this brand, such as Fel-O-Guard Plus 4 (now marketed as TruFel HCP+CH), protect against Feline Rhinotracheitis, Calicivirus, Panleukopenia, and Chlamydia psittaci. Other variants, like Fel-O-Guard Plus 3 + Lv-K (now TruFel HCP+FELV), also include protection against Feline Leukemia virus. These vaccines typically utilize a combination of modified live viruses for core diseases (Rhinotracheitis, Calicivirus, Panleukopenia) and killed antigens for others (Chlamydia psittaci, Feline Leukemia virus) to stimulate an immune response. The vaccine is administered subcutaneously to healthy cats eight weeks of age or older. The Fel-O-Guard vaccine portfolio was originally developed by Boehringer Ingelheim Vetmedica and later acquired by Elanco Animal Health.
- Brand names
- Fel-O-GuardFel-O-Guard Plus 4Fel-O-Guard Plus 3 + Lv-K
- Other names
- TruFel HCP+CHTruFel HCP+Ch-FeLVTruFel HCP+FELV
02
Targets
FPV (Feline panleukopenia virus)
Beyond the preview
Go deeper on Fel-O-Guard.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Fel-O-Guard.